Evkeeza
Nasopharyngitis, influenza-like illness, dizziness, rhinorrhea, nausea; hypersensitivity reactions.
Categoría: Meditation
Stock disponible: 12
Descripción del producto
Discontinue if serious hypersensitivity reactions occur; monitor and treat appropriately. Assess LDL-C when clinically appropriate; effects may be measured as early as 2 weeks after initiation. Embryo-fetal toxicity. Advise females of reproductive potential to use effective contraception during and for at least 5 months after the last dose. Pregnancy: exclude status prior to initiation. Nursing mothers.
Marca | Angiopoietin-like 3 (ANGPTL3) inhibitor. |
---|---|
Ubicación en la que está disponible el producto | hgh |
Nombre Del Almacén | fdfghgh |
Ubicación Del Almacén | fgfg |